According to Purdue University’s Ag Economy Barometer survey in July, high input costs and lower crop and livestock prices are the top two concerns on farmers mind at the moment. For agbioscience innovators, it’s a critical more than ever to consider moves that can deliver maximum value to the farmer. Dave Pugh, CFO of AgReliant Genetics, joins us as GDM recently announced its agreement to acquire the company. We get into:  

• Dave’s background in computer science and risk management + what drew him to agbioscience 
• Massive validation in the form of GDM’s agreement to acquire AgReliant Genetics and what that means for the farmer 
• How Dave thinks through the investment of innovation in agbioscience in a time of uncertainty for farmers and companies alike 
• The AgReliant Genetics portfolio heading into acquisition and its strengths in corn genetics 
• His perspective on the relationship between seed brands and customer 
• Dave’s finance background and role as CFO – in a time of uncertainty – planning for oversight of what’s ahead and how to stay innovative in the process 
• What has him most excited about what’s ahead with GDM 

The following conversation discusses the recent announcement that GDM is seeking to acquire AgReliant Genetics. The transaction is subject to regulatory approvals in the United States and other customary closing conditions and approvals. Until the necessary approvals and closing conditions are obtained and satisfied and the transaction has closed, GDM and AgReliant Genetics will continue to operate as independent entities, maintaining their current business routines and commercial structures.